A "new" HLA-C specificity, CSH-2, restricted to Oriental populations

Area of Science:

• Immunogenetics
• Human Leukocyte Antigen (HLA) system
• Population genetics

Background:

• The C-locus of the Human Leukocyte Antigen (HLA) system exhibits a high frequency of blank alleles across diverse human populations.
• This observation suggests the presence of an undiscovered antigen, contributing to the complexity of HLA typing and population-specific genetic variations.

Purpose of the Study:

• To identify and characterize the novel C-locus antigen responsible for the observed blank alleles.
• To determine the population distribution of this newly identified antigen, particularly its presence in Oriental, Caucasoid, and Black populations.

Main Methods:

• Planned immunization was employed to generate specific antibodies against potential unknown antigens.
• A monospecific antiserum, designated ZHA114, was developed and characterized for its reactivity.
• Serological analysis was performed to define the specificity of the new antigen using the ZHA114 antiserum.

Main Results:

• A new C-locus antigen, tentatively named CSH-2, was identified.
• The ZHA114 antiserum demonstrated strong monospecific reactivity, confirming the presence of the CSH-2 specificity.
• CSH-2 was found to be present in Oriental populations but apparently absent in Caucasoid and Black populations.

Conclusions:

• The discovery of the CSH-2 antigen provides a molecular explanation for previously undetected C-locus blank alleles in Oriental populations.
• CSH-2 represents a population-specific antigen, highlighting the importance of considering ethnic variations in HLA research and clinical applications.
• Further studies are warranted to fully elucidate the genetic basis and clinical significance of the CSH-2 antigen.